文献速递真菌感染艾滋病与性传播感染

2020年全球成人HIV相关隐球菌感染负担:一项模型分析

The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis.
PubMed 文献 · Lancet Infect Dis · 2022-08-29

该模型分析基于UNAIDS估计和文献综述,估算2020年全球CD4计数低于200个/μL的HIV成人中隐球菌抗原血症、隐球菌脑膜炎及隐球菌相关死亡负担。

要点

  • 隐球菌疾病占AIDS相关死亡的19%(13-24),与2014年估计相似。

核心结论

  • 尽管相比2014年全球HIV相关隐球菌脑膜炎估计绝对负担有所下降(可能因抗逆转录病毒治疗扩大),隐球菌疾病仍占AIDS相关死亡的19%,与2014年估计相似。
  • 作者认为,为在2030年前终结隐球菌脑膜炎死亡,迫切需要隐球菌诊断、脑膜炎治疗及预防性筛查的实施。

研究设计与样本

  • 该研究为模型分析,将晚期HIV疾病定义为CD4计数低于200个/μL的成人。
  • 利用UNAIDS估计(2019-20)和基于人群的HIV影响评估调查(2016-18)估算各国及各区域CD4<200个/μL的成人数量。
  • 通过综述已发表文献总结CD4<200个/μL人群中隐球菌抗原血症患病率。
  • 将晚期HIV疾病风险人数乘以相应国家或区域的隐球菌抗原血症患病率计算CrAg阳性人数。
  • 基于已发表文献估计从隐球菌抗原血症进展为脑膜炎或死亡的比例。

主要发现

  • 全球范围内隐球菌疾病占AIDS相关死亡的19%(13-24)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cryptococcal meningitis is the most common cause of meningitis in adults living with HIV in sub-Saharan Africa. The estimates of national, regional, and global burden of cryptococcal meningitis are essential to guide prevention strategies and determine needs for diagnostic tests and treatments. We present a 2020 estimate of the global burden of HIV-associated cryptococcal infection (antigenaemia), cryptococcal meningitis, and cryptococcal-associated deaths. METHODS: We defined advanced HIV disease as adults with a CD4 count of less than 200 cells/μL, as this group is at highest risk for cryptococcosis. We used UNAIDS estimates (2019-20) and population-based HIV impact assessment surveys (2016-18) to estimate the number of adults with CD4 counts of less than 200 cells/μL at risk for cryptococcosis, by country and region. Secondly, we summarised cryptococcal antigenaemia prevalence in those with a CD4 count of less than 200 cells/μL by reviewing published literature. Thereafter, we calculated the number of cryptococcal antigen (CrAg)-positive people in each country and region by multiplying the number with advanced HIV disease at risk for cryptococcal infection by the cryptococcal antigenaemia prevalence of the respective country or region. We estimated progression from cryptococcal antigenaemia to meningitis or death based on estimates from the published literature. FINDINGS: We estimated that there were 4·3 million (IQR 3·0-4·8) adults with HIV and CD4 counts of less than 200 cells/μL globally in 2020. We calculated a mean global cryptococcal antigenaemia prevalence of 4·4% (95% CI 1·6-7·4) among HIV-positive people with CD4 counts of less than 200 cells/μL, corresponding to 179 000 cases (IQR 133 000-219 000) of cryptococcal antigenaemia globally in 2020. Annually, we estimated that there are 152 000 cases (111 000-185 000) of cryptococcal meningitis, resulting in 112 000 cryptococcal-related deaths (79 000-134 000). Globally, cryptococcal disease accounts for 19% (13-24) of AIDS-related mortality. INTERPRETATION: Despite a reduction in the estimated absolute global burden of HIV-associated cryptococcal meningitis compared with 2014, likely to be due to antiretroviral therapy expansion, cryptococcal disease still accounts for 19% of AIDS-related deaths, similar to 2014 estimates. To end cryptococcal meningitis deaths by 2030, cryptococcal diagnostics, meningitis treatments, and implementation of preventive screening are urgently needed. FUNDING: None.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Rajasingham R, Govender NP, Jordan A, et al. The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis. Lancet Infect Dis. 2022. PMID: 36049486. doi:10.1016/S1473-3099(22)00499-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。